(Q34369116)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24010812%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Review article: autoimmune hepatitis -- current management and challenges (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24010812%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24010812%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

K Zachou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24010812%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

P Muratori

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24010812%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

G K Koukoulis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24010812%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

N Gatselis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24010812%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

A Fabbri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24010812%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

G N Dalekos

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24010812%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

L Muratori

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24010812%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

English

0 references

publication date

8 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24010812%20AND%20SRC:MED&resulttype=core&format=json

Alimentary Pharmacology & Therapeutics

20 February 2020

number of pages

27

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24010812%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24010812%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24010812%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

887-913

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24010812%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

21 January 2018

1 reference

Simplified criteria for the diagnosis of autoimmune hepatitis

21 January 2018

1 reference

Epidemiology of autoimmune liver disease

21 January 2018

1 reference

Population-based epidemiology study of autoimmune hepatitis: a disease of older women?

21 January 2018

1 reference

Autoimmune hepatitis in African Americans: presenting features and response to therapy

21 January 2018

1 reference

The impact of race/ethnicity on the clinical epidemiology of autoimmune hepatitis.

21 January 2018

1 reference

Genetic bases of autoimmune hepatitis.

21 January 2018

1 reference

Genetic distinctions between autoimmune hepatitis in Italy and North America

21 January 2018

1 reference

Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis

21 January 2018

1 reference

Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition

21 January 2018

1 reference

Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States.

21 January 2018

1 reference

Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2.

21 January 2018

1 reference

Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.

21 January 2018

1 reference

Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.

21 January 2018

1 reference

Enzymes as target antigens of liver-specific autoimmunity: the case of cytochromes P450s.

21 January 2018

1 reference

Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.

21 January 2018

1 reference

Human FoxP3+ regulatory T cells in systemic autoimmune diseases

21 January 2018

1 reference

Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.

21 January 2018

1 reference

Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis.

21 January 2018

1 reference

Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis

21 January 2018

1 reference

A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens

21 January 2018

1 reference

Forkhead box p3+ regulatory T cell underlies male resistance to experimental type 2 autoimmune hepatitis

21 January 2018

1 reference

Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection

21 January 2018

1 reference

Autoimmune acute liver failure: proposed clinical and histological criteria

21 January 2018

1 reference

Acute presentation of autoimmune hepatitis: Does it exist? A published work review

21 January 2018

1 reference

Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type

21 January 2018

1 reference

Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases.

21 January 2018

1 reference

Autoimmune hepatitis in Italy: the Bologna experience

21 January 2018

1 reference

Clinical features of Japanese male patients with type 1 autoimmune hepatitis

21 January 2018

1 reference

Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study.

21 January 2018

1 reference

Clinical features of type 1 autoimmune hepatitis in elderly Italian patients

21 January 2018

1 reference

Diagnosis and treatment of autoimmune hepatitis at age 65 and older

21 January 2018

1 reference

Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.

21 January 2018

1 reference

Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients.

21 January 2018

1 reference

Management and outcome of pregnancy in autoimmune hepatitis

21 January 2018

1 reference

Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery

21 January 2018

1 reference

Outcomes of pregnancy in women with autoimmune hepatitis.

21 January 2018

1 reference

Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease

21 January 2018

1 reference

Drug-induced autoimmune-like hepatitis

21 January 2018

1 reference

Autoimmune hepatitis triggered by nitrofurantoin: a case series

21 January 2018

1 reference

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.

21 January 2018

1 reference

The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.

21 January 2018

1 reference

Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate

21 January 2018

1 reference

Is there a role for viruses in triggering autoimmune hepatitis?

21 January 2018

1 reference

Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals

21 January 2018

1 reference

A case of autoimmune hepatitis needed to be differentiated from EBV hepatitis, in that the histology of liver biopsy specimen was useful for diagnosis

21 January 2018

1 reference

De novo autoimmune hepatitis after liver transplantation

21 January 2018

1 reference

Plasma cell hepatitis (de-novo autoimmune hepatitis) developing post liver transplantation

21 January 2018

1 reference

Celiac disease in pediatric patients with autoimmune hepatitis: etiology, diagnosis, and management.

21 January 2018

1 reference

The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders

21 January 2018

1 reference

Occult hepatitis B virus infection in patients with autoimmune liver diseases

21 January 2018

1 reference

Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score?

21 January 2018

1 reference

Hepatocellular carcinoma in patients with autoimmune hepatitis.

21 January 2018

1 reference

Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening.

21 January 2018

1 reference

Mortality and the risk of malignancy in autoimmune liver diseases: A population-based study in Canterbury, New Zealand

21 January 2018

1 reference

Hepatocellular carcinoma and survival in patients with autoimmune hepatitis (Japanese National Hospital Organization-autoimmune hepatitis prospective study).

21 January 2018

1 reference

Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis

21 January 2018

1 reference

Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1.

21 January 2018

1 reference

Diagnosis and management of autoimmune hepatitis

21 January 2018

1 reference

Definition and classification of autoimmune hepatitis

21 January 2018

1 reference

Smooth muscle antibodies and type 1 autoimmune hepatitis

21 January 2018

1 reference

Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis

21 January 2018

1 reference

Diagnostic relevance of anti-filamentous actin antibodies in autoimmune hepatitis

21 January 2018

1 reference

Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile

21 January 2018

1 reference

Impact of pretransplant antinuclear antibody and antismooth muscle antibody titers on disease recurrence and graft survival following liver transplantation in autoimmune hepatitis patients

21 January 2018

1 reference

Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis

21 January 2018

1 reference

Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas

21 January 2018

1 reference

Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis

21 January 2018

1 reference

Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics

21 January 2018

1 reference

Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study

21 January 2018

1 reference

Autoantibody-negative autoimmune hepatitis

21 January 2018

1 reference

RNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaea

21 January 2018

1 reference

The Human SepSecS-tRNASec Complex Reveals the Mechanism of Selenocysteine Formation

21 January 2018

1 reference

Significance of antibodies to soluble liver antigen/liver pancreas: a large French study.

21 January 2018

1 reference

Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis

21 January 2018

1 reference

Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody

21 January 2018

1 reference

LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase

21 January 2018

1 reference

Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C.

21 January 2018

1 reference

Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease

21 January 2018

1 reference

Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece

21 January 2018

1 reference

Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C.

21 January 2018

1 reference

Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C.

21 January 2018

1 reference

Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C.

21 January 2018

1 reference

Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C.

21 January 2018

1 reference

Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus

21 January 2018

1 reference

Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance

21 January 2018

1 reference

Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection

21 January 2018

1 reference

Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis

21 January 2018

1 reference

Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis

21 January 2018

1 reference

Polyclonal hypergammaglobulinemia and high smooth-muscle autoantibody titers with specificity against filamentous actin: consider visceral leishmaniasis, not just autoimmune hepatitis

21 January 2018

1 reference

Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis

21 January 2018

1 reference

Characterization of anti-histone antibodies in patients with type 1 autoimmune hepatitis

21 January 2018

1 reference

Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis

21 January 2018

1 reference

Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA--revival of a disease-activity marker in autoimmune hepatitis.

21 January 2018

1 reference

Frequency and significance of antibodies to chromatin in autoimmune hepatitis

21 January 2018

1 reference

Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis

21 January 2018

1 reference

Alpha-actinin: a multidisciplinary protein with important role in B-cell driven autoimmunity

21 January 2018

1 reference

Frequency and significance of antibodies to Saccharomyces cerevisiae in autoimmune hepatitis

21 January 2018

1 reference

Molecular diagnostics of primary biliary cirrhosis

21 January 2018

1 reference

Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis.

21 January 2018

1 reference

Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis

21 January 2018

1 reference

Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases

21 January 2018

1 reference

Anti-alpha-actinin antibodies: a new marker of lupus nephritis

21 January 2018

1 reference

Diagnosis and treatment of autoimmune hepatitis

21 January 2018

1 reference

Asialoglycoprotein receptor facilitates hemolysis in patients with alcoholic liver cirrhosis

21 January 2018

1 reference

Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis.

21 January 2018

1 reference

Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis

21 January 2018

1 reference

Autoimmune hepatitis and overlap syndromes

21 January 2018

1 reference

Autoimmune hepatitis: a histological variant associated with prominent centrilobular necrosis

21 January 2018

1 reference

Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis

21 January 2018

1 reference

Histology of autoimmune hepatitis and its variants

21 January 2018

1 reference

Overlap syndromes among autoimmune liver diseases

21 January 2018

1 reference

The hepatitic/cholestatic "overlap" syndrome: an Italian experience

21 January 2018

1 reference

Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue

21 January 2018

1 reference

Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome.

21 January 2018

1 reference

The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome.

21 January 2018

1 reference

Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases.

21 January 2018

1 reference

21 January 2018

1 reference

Identification and characterization of IgG4-associated autoimmune hepatitis

21 January 2018

1 reference

Clinical significance of immunoglobulin G4-associated autoimmune hepatitis

21 January 2018

1 reference

Review article: overlap syndromes and autoimmune liver disease

21 January 2018

1 reference

Diagnostic criteria for autoimmune hepatitis

21 January 2018

1 reference

Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease.

21 January 2018

1 reference

Clinical features of autoimmune hepatitis diagnosed based on simplified criteria of the International Autoimmune Hepatitis Group.

21 January 2018

1 reference

Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute-onset autoimmune hepatitis.

21 January 2018

1 reference

Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis

21 January 2018

1 reference

Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis

21 January 2018

1 reference

Review article: immunopathogenetic and therapeutic aspects of autoimmune hepatitis

21 January 2018

1 reference

Treatment response in patients with autoimmune hepatitis

21 January 2018

1 reference

Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs.

21 January 2018

1 reference

Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials

21 January 2018

1 reference

Clinical pharmacology and pharmacogenetics of thiopurines

21 January 2018

1 reference

Thiopurine S-methyltransferase gene polymorphism in Japanese patients with autoimmune liver diseases

21 January 2018

1 reference

Current and future treatments of autoimmune hepatitis

21 January 2018

1 reference

Diagnosis and treatment of autoimmune hepatitis

21 January 2018

1 reference

Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission

21 January 2018

1 reference

Current topics in autoimmune hepatitis

21 January 2018

1 reference

Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis

21 January 2018

1 reference

Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis

21 January 2018

1 reference

Short-term cyclosporine induces a remission of autoimmune hepatitis in children.

21 January 2018

1 reference

Effectiveness and safety of ciclosporin as therapy for autoimmune diseases of the liver in children and adolescents.

21 January 2018

1 reference

Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases?

21 January 2018

1 reference

Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.

21 January 2018

1 reference

Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy

21 January 2018

1 reference

Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus

21 January 2018

1 reference

Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.

21 January 2018

1 reference

Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up.

21 January 2018

1 reference

Mycophenolate mofetil for autoimmune hepatitis: a single practice experience

21 January 2018

1 reference

Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease

21 January 2018

1 reference

Mycophenolate mofetil as second line therapy in autoimmune hepatitis?

21 January 2018

1 reference

Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy

21 January 2018

1 reference

A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis

21 January 2018

1 reference

Rapidity of treatment response and outcome in type 1 autoimmune hepatitis

21 January 2018

1 reference

Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis

21 January 2018

1 reference

Promising pharmacological, molecular and cellular treatments of autoimmune hepatitis

21 January 2018

1 reference

Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease

21 January 2018

1 reference

Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis.

21 January 2018

1 reference

Use of a xanthine oxidase inhibitor in autoimmune hepatitis.

21 January 2018

1 reference

Pregnancy outcome in women with autoimmune hepatitis

21 January 2018

1 reference

Follow-up of pregnant women with autoimmune hepatitis: the disease behavior along with maternal and fetal outcomes.

21 January 2018

1 reference

Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.

21 January 2018

1 reference

Prospective analysis of nonadherence in autoimmune hepatitis: a common problem.

21 January 2018

1 reference

Identifying opportunities to improve management of autoimmune hepatitis: evaluation of drug adherence and psychosocial factors.

21 January 2018

1 reference

Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival

21 January 2018

1 reference

A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis

21 January 2018

1 reference

Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.

21 January 2018

1 reference

Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis

21 January 2018

1 reference

Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs

21 January 2018

1 reference

Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells

21 January 2018

1 reference

Corticosteroids do not reverse the inhibitory effect of cyclosporine on regulatory T-cell activity in contrast to mycophenolate mofetil

21 January 2018

1 reference

Mycophenolate mofetil promotes down-regulation of expanded B cells and production of TNF-alpha in an experimental murine model of colitis

21 January 2018

1 reference

Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells

21 January 2018

1 reference

Rapamycin does not induce anergy but inhibits expansion and differentiation of alloreactive human T cells

21 January 2018

1 reference

Rapamycin successfully treats post-transplant autoimmune hepatitis

21 January 2018

1 reference

A Case of Autoimmune Hepatitis Treated with Rituximab

21 January 2018

1 reference

Neutropenia after rituximab treatment: new insights on a late complication

21 January 2018

1 reference

Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: A hidden threat

21 January 2018

1 reference

TNF-α is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression

21 January 2018

1 reference

Autoimmune hepatitis: a comprehensive review

21 January 2018

1 reference

Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis

21 January 2018

1 reference

Biologics-induced autoimmune diseases

21 January 2018

1 reference

Use of TNFα antagonists in refractory AIH: revealing the unforeseen

21 January 2018

1 reference

The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies

21 January 2018

1 reference

Liver transplantation in autoimmune liver diseases

21 January 2018

1 reference

Long-term outcome of liver transplantation for autoimmune hepatitis

21 January 2018

1 reference

Risk factors for recurrence of autoimmune hepatitis after liver transplantation.

21 January 2018

1 reference

Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease

21 January 2018

1 reference

Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases

21 January 2018

1 reference

Antilactoferrin antibodies in autoimmune liver disease

21 January 2018

1 reference

'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?

21 January 2018

1 reference

Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1

21 January 2018

1 reference

Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis

21 January 2018

1 reference

FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency

21 January 2018

1 reference

Autoimmune hepatitis in the elderly

21 January 2018

1 reference